Mike Hollan

Leaders must address the root causes of negative public perception.

BioXcel’s VP of AI drug discovery discusses how use of the technology has advanced in the past year.

The device will be 4g-enabled and connect with the company’s remote monitoring platform.

The two companies are combining digital platforms to provide prescribers more options to monitor patients’ medication adherence.

Hypermedica and Ro announced platforms to help patients find access to affordable weight loss medications.

Both systems are over-the-counter products that provide continuous glucose monitoring.

Both partnerships will bring new research and healthcare opportunities to Abu Dhabi.

The partnership is described as the first of its kind.

The new agency will operate under the name Deerfield Group, and will also include Verge Scientific Communications.

The organization announced greater support for access and services for the community.

Anat Ashkenazi will leave the company at the end of July to pursue a career outside of pharma.

EVERSANA INTOUCH Media’s EVP discusses how the ban may impact the industry and how companies can prepare for it.

BD announced that it will pay cash to acquire the advanced monitoring solutions company.

Experts discuss the challenges that providers are facing when attempting to bring VBC to their members.

The Tarsus Pharmaceuticals CEO discusses the ways that his company is finding solutions that may have been overlooked.

The drug had previously been submitted, but required resubmission due to production issues.

The platforms are described as being first-in-category for the pharma industry.

Alkermes’ chief information officer discusses how he helped develop and build a welcoming workplace.

Multiple surveys show that older voters are concerned about the cost of healthcare and Medicare, along with other financial concerns.

The company will present research from multiple projects completed in collaboration with multiple partners.

The company will offer clients access to spectral data files.

The Statistical Computing Environment Coalition aims to improve data flow and gets drugs approved more quickly.

Slack, CEO and chairman for START Center for Cancer Research, discusses the complications that patients have getting enrolled in clinical trials.

The CEO of AION Labs discusses both the new ways that AI is being implemented in drug development and why Israel is becoming the center of AI development in the pharma industry.

The company is collaborating with CPESN USA to bring more services to customers at independent pharmacies across the country.

Cityblock is partnering with Sunshine Health in Florida.

Cencora’s associate director of value and access strategy for its commercialization strategy & access solutions division discusses the current state of pre-approval information exchanges.

Inizio’s chief operations officer discusses how pharmaceutical companies are tailoring their product launch strategies to meet the diverse needs of stakeholders.

Experts discuss how new innovations are changing the relationship the industry has with patients.

Experts discuss how attempts to solve the drug pricing problem in the US are working.